- Home
- LPTX vs FNWD Comparison
LPTX vs FNWD Comparison
Compare LPTX & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- FNWD
- Stock Information
- Founded
- LPTX 2011
- FNWD 1994
- Country
- LPTX United States
- FNWD United States
- Employees
- LPTX N/A
- FNWD N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- FNWD Savings Institutions
- Sector
- LPTX Health Care
- FNWD Finance
- Exchange
- LPTX Nasdaq
- FNWD Nasdaq
- Market Cap
- LPTX 119.6M
- FNWD 117.3M
- IPO Year
- LPTX N/A
- FNWD N/A
- Fundamental
- Price
- LPTX $2.55
- FNWD $27.01
- Analyst Decision
- LPTX Strong Buy
- FNWD
- Analyst Count
- LPTX 3
- FNWD 0
- Target Price
- LPTX $7.50
- FNWD N/A
- AVG Volume (30 Days)
- LPTX 335.2K
- FNWD 3.2K
- Earning Date
- LPTX 11-13-2024
- FNWD 01-28-2025
- Dividend Yield
- LPTX N/A
- FNWD 1.78%
- EPS Growth
- LPTX N/A
- FNWD 7.22
- EPS
- LPTX N/A
- FNWD 2.71
- Revenue
- LPTX N/A
- FNWD $69,627,000.00
- Revenue This Year
- LPTX N/A
- FNWD N/A
- Revenue Next Year
- LPTX N/A
- FNWD $1.04
- P/E Ratio
- LPTX N/A
- FNWD $9.97
- Revenue Growth
- LPTX N/A
- FNWD 3.96
- 52 Week Low
- LPTX $1.68
- FNWD $22.82
- 52 Week High
- LPTX $4.79
- FNWD $33.50
- Technical
- Relative Strength Index (RSI)
- LPTX 37.35
- FNWD 32.47
- Support Level
- LPTX $2.88
- FNWD $27.02
- Resistance Level
- LPTX $3.27
- FNWD $27.81
- Average True Range (ATR)
- LPTX 0.28
- FNWD 0.52
- MACD
- LPTX -0.06
- FNWD -0.10
- Stochastic Oscillator
- LPTX 12.71
- FNWD 3.68
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.